CAS 1644539-04-7

Eptinezumab

CAS : 1644539-04-7

Anti-Human CGRP Monoclonal Antibody

Ref: 3D-CLA1444

Eptinezumab

CAS : 1644539-04-7

Eptinezumab is a humanised monoclonal antibody targeting CGRP (calcitonin gene-related peptide), which prevents CGRP binding to its receptor, migraine.

Degré de pureté : 95% - 96.9% (SDS-PAGE); 99.8% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 143.27 kDa

Ref: TM-T76678